SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-040690
Filing Date
2004-03-12
Accepted
2004-03-12 17:17:08
Documents
13
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2003 d10k.htm 10-K 1240313
3 EMPLOYEE CONFIDENIALITY, INVENTION ASSIGNMENT AND NON-COMPETE AGREEMENT dex1035.htm EX-10.35 28396
4 SECOND ADMENDMENT TO SUBLEASE AND CONSENT BETWEEN ICAGEN, INC. dex1036.htm EX-10.36 14298
5 AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY dex1037.htm EX-10.37 7955
6 MILEAGE ANALYSIS AGREEMENT dex1038.htm EX-10.38 151551
7 MASTER LEASE AGREEMENT BETWEEN GE LIFE SCIENCE AND TECHNOLOGY FINANCE dex1039.htm EX-10.39 102199
8 INDEPENDENT ACCOUNTANTS dex231.htm EX-23.1 1505
9 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8793
10 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8795
11 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4478
12 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4480
13 GRAPHIC g28602image002.jpg GRAPHIC 8866
14 GRAPHIC g28602image1.jpg GRAPHIC 22058
  Complete submission text file 0001193125-04-040690.txt   1606834
Mailing Address 4222 EMPEROR BLVD STE 470 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 470 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 001-31577 | Film No.: 04666965
SIC: 2834 Pharmaceutical Preparations